Published on 9 May 2024 on Simply Wall St. via Yahoo Finance
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) investors will be delighted, with the company turning in some strong numbers with its latest results. Results overall were solid, with revenues arriving 2.4% better than analyst forecasts at US$145m. Higher revenues also resulted in substantially lower statutory losses which, at US$0.16 per share, were 2.4% smaller than the analysts expected. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
See our latest analysis for Intra-Cellular Therapies
